Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,098 public trials 1,201 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Terminated

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

NCT04246177

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Arizona Oncology Associates PC- HOPE ( Site 0770) Tucson, Arizona, United States
  • Scripps Clinic Torrey Pines ( Site 0714) La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center ( Site 0717) Los Angeles, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0720) Los Angeles, California, United States
View all 205 locations
View Trial Details
Terminated

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

NCT04601428

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • National Cheng Kung University Hospital (NCKUH) Tainan, North Dist., Taiwan
  • Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC) Taipei, Pei-Tou Dist., Taiwan
  • National Taiwan University Hospital (NTUH) Taipei, Zhongzheng Dist., Taiwan
  • KFSYSCC Taipei, Taiwan
View Trial Details
Terminated

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

NCT01216371

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations
  • Universitätsmedizin Charité Berlin Berlin, Germany
  • Franziskus Krankenhaus Berlin, Germany
  • Helios Klinikum Emil von Behring Berlin, Germany
  • university hospital of Düsseldorf Düsseldorf, Germany
View Trial Details
Terminated

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

NCT05435014

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Tungs' Taichung Metroharbor Hospital Taichung, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Terminated

A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma

NCT03656536

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Georgetown University-Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 215 locations
View Trial Details
Terminated

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

NCT05199285

Conditions
Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +19 more
Locations
  • University of Alabama- Birmingham Birmingham, Alabama, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions